scispace - formally typeset
D

Dan Garza

Researcher at Novartis

Publications -  30
Citations -  3635

Dan Garza is an academic researcher from Novartis. The author has contributed to research in topics: Proteostasis & Protein folding. The author has an hindex of 17, co-authored 27 publications receiving 3284 citations.

Papers
More filters
Journal ArticleDOI

HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

TL;DR: It is shown that autophagy acts as a compensatory degradation system when the UPS is impaired in Drosophila melanogaster, and that histone deacetylase 6 (HDAC6), a microtubule-associated de acetylase that interacts with polyubiquitinated proteins, is an essential mechanistic link in this compensatory interaction.
Journal ArticleDOI

A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.

TL;DR: A critical chaperome subnetwork that functions in aging and disease is identified using function, localization, interactome, and expression data sets to identify repression and induction clusters in human brain aging.
Journal ArticleDOI

Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells

TL;DR: TORCs represent a family of highly conserved CREB coactivators that may control the potency and specificity of CRE-mediated responses and represent an unbiased method for systematically determining gene function in mammalian cells.
Journal ArticleDOI

Activation of cAMP Response Element-Mediated Gene Expression by Regulated Nuclear Transport of TORC Proteins

TL;DR: TORC function was shown to be essential for CRE-mediated gene expression induced by cAMP, calcium, or GPCR activation, and nuclear transport of TORC1 was sufficient to activate CRE-dependent transcription.
Journal ArticleDOI

Small-molecule proteostasis regulators for protein conformational diseases

TL;DR: It is suggested that modulation of the proteostasis network by PRs represents a promising therapeutic approach for the treatment of a variety of protein conformational diseases.